Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L1VF
|
|||
| Drug Name |
PH-10
|
|||
| Synonyms |
Rose Bengal sodium salt; Bengal Rose B sodium salt; CI Acid red 94; NCGC00159508-02; disodium 2,3,4,5-tetrachloro-6-(2,4,5,7-tetraiodo-3-oxido-6-oxoxanthen-9-yl)benzoate; DSSTox_CID_2814; ph-10; AC1L1NH9; AC1MC45U; DSSTox_RID_76740; DSSTox_GSID_22814; DTXSID4022814; CHEMBL2359093; CTK8G2989; Rose bengal, Dye content 95 %; UWBXIFCTIZXXLS-UHFFFAOYSA-L; Tox21_111727; MFCD00005043; GT2559; AKOS015902615; AKOS024319604; MCULE-2782240614; CAS-632-69-9; Tetrachlorotetraiodofluorescein disodium salt; ST50411638; F000
Click to Show/Hide
|
|||
| Indication | Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Phase 2 | [1], [2] | |
| Company |
Provectus Biopharmaceuticals Knoxville, TN
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H2Cl4I4Na2O5
|
|||
| Canonical SMILES |
C1=C2C(=C3C=C(C(=O)C(=C3OC2=C(C(=C1I)[O-])I)I)I)C4=C(C(=C(C(=C4Cl)Cl)Cl)Cl)C(=O)[O-].[Na+].[Na+]
|
|||
| InChI |
1S/C20H4Cl4I4O5.2Na/c21-10-8(9(20(31)32)11(22)13(24)12(10)23)7-3-1-5(25)16(29)14(27)18(3)33-19-4(7)2-6(26)17(30)15(19)28;;/h1-2,29H,(H,31,32);;/q;2*+1/p-2
|
|||
| InChIKey |
UWBXIFCTIZXXLS-UHFFFAOYSA-L
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.